Avian polyomavirus: a recent update by Mohd Padzil, Muhamad Faiz et al.
J. Vet. Malaysia (2017) 29 (2):9-13 
9 
 
Review Articles 
 
AVIAN POLYOMAVIRUS: A RECENT UPDATE 
 
F. Padzil1, A. R. Mariatulqabtiah1,2* and J. Abu3 
 
1Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, Malaysia 
2Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, UPM Serdang, Malaysia 
3Faculty of Veterinary Medicine, Universiti Putra Malaysia, UPM Serdang, Malaysia 
 
SUMMARY 
 
Avian polyomavirus disease is among the most common viral diseases of domesticated exotic birds as such in 
psittacine families. Caused by avian polyomavirus (APV) which possess a circular, double-stranded DNA which 
encodes for major structural virus protein 1 (VP1) and minor structural proteins VP2, VP3 and VP4, the disease is also 
known as Budgerigar fledgling disease polyomavirus (BFPyV), Papovavirus, and Psittacine polyomavirus. Infections 
from APV may lead to cutaneous haemorrhage, abdominal distension, feather abnormalities and even death. The APV 
virus has a broad avian host range and is known to cause acute chronic disease in several psittacine birds such as parrot, 
cockatoo, macaw, and budgerigar. The current status of APV epidemiology globally has not been fully recorded. Only 
the studies of the virus and disease caused within several countries are used as references, and few were done together 
with detection of beak and feather disease virus. Despite the common occurrence of APV among bird breeders in 
Malaysia, a very limited study has been done to evaluate the prevalence status of APV in Malaysia. In this review, we 
wish to disseminate knowledge, particularly to pet owners and bird breeders, on APV characterisations, its updated 
occurrence worldwide and prevention strategies. This information may be useful to trigger in depth study on the 
epidemiology of disease and better management practises among breeders. 
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INTRODUCTION 
 
Avian polyomavirus disease is among the most 
common viral diseases of domesticated exotic birds as 
such in psittacine families. Caused by avian polyomavirus 
(APV), the disease is also known as Budgerigar fledgling 
disease polyomavirus (BFPyV), Papovavirus, and 
Psittacine polyomavirus (Hsu et al., 2006). The infection 
of this virus is reported globally, and the first case was 
discovered in young budgerigars (Melopsittacus 
undulatus) in 1981 (Tomasek et al., 2007). The APV virus 
has a broad avian host range and is known to cause acute 
chronic disease in several psittacine birds such as parrot, 
cockatoo, macaw, and budgerigar. Many incidences of 
APV linked diseases have been reported in young captive 
birds with high mortality rates (Parrish, 2011). Even 
though the International Committee on Taxonomy of 
Viruses appointed the virus name as budgerigar fledgling 
polyomavirus, but due to its wide host range among avian 
species, it is now called APV (Katoh et al., 2009). The 
distinct biological and molecular traits of this virus 
making it being proposed to another different subgenus 
Avipolyomavirus within the genus Polyomavirus (Johne et 
al., 2000). The aim of this review is to disseminate 
knowledge on APV characterisations and its current 
worldwide occurrence. 
 
Avian Polyomavirus Structure and Genome 
 
APV is a virus under the family of Polyomaviridae 
and genus Avipolyomavirus. It is an unenveloped virus  
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with icosahedral viral capsid containing circular double-
stranded DNA, with a genome size of 4981 bp (Johne et 
al., 2000; Hsu et al., 2006). The DNA has covalently 
closed ends and complexed with cellular histones in 
supercoiled form (Johne and Muller, 2003; Parrish, 2011). 
The icosahedral viral capsid has T=7 symmetry, with 
diameter around 40-45 nm and comprised with 72 
pentamers. The details on the structure of the 
polyomavirus particle have been well described using X-
ray crystallography (Johne and Muller, 2003).  
The APV genomes can be categorized into two 
regions; an early region which codes for tumour (T) 
antigen, and late region which encodes for structural 
proteins (Katoh et al., 2009). Tumour antigen encoded in 
the early genes of APV is responsible for viral genome 
replication as well as host cell transformation (Halami et 
al., 2010). The late region expression is complexed by 
two putative promoter regions, together with alternative 
and partial splicing activities (Johne et al., 2000).  The 
genome of APV also contains the non-coding regions or 
regulatory controls which consist of origin of replication 
(ori), promoter-enhancer sequences and transcription start 
site (TSS). Starting from the short non-coding regulatory 
region, both of the early and late regions are being 
transcribed bi-directionally (Halami et al., 2010).   
The structural proteins encode within the late region 
are recognised as major structural virus protein 1 (VP1) 
and minor structural proteins VP2, VP3 and VP4. VP1 is 
the major capsid protein of Polyomaviridae. It is 
expressed from VP1 gene of 1032-bp, identified from 
complete genome of APV at region 1899-2930 (NCBI 
Accession Number: NC_004764). A capsomer of 
polyomavirus particle is represented by five molecules of 
VP1 assembled into a pentametric complex which 
interacts with either, VP2 and VP3 (Johne and Muller, 
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2003). Virus-like particle (VLP) of APV has been 
successfully formed via chicken embryo (CE) cells 
permissive, where the replication of RNA polymerase 1-
based recombinant influenza viruses induced the 
coexpression of VLP, which is correlated to the nuclear 
localization of VP1 (Johne and Muller, 2003). 
The VP2 and VP3 are translated from the same open 
reading frame (ORF) but with a different start codon 
(Halami et al., 2010). The structure of VP3 is similar to 
the C-terminal region of V2 (Johne and Muller, 2003). A 
distinct characteristic of avian polyomaviruses from other 
groups within the genus is the presence of VP4. In the 
upstream of the VP2 coding region in the avian 
polyomaviruses, an additional ORF is present which 
encodes VP4 (Halami et al., 2010). The VP4 protein with 
molecular weight of 32 kDa is important for APV 
replication (Katoh et al., 2009). It also interacts with VP1 
and double stranded DNA (Johne and Muller, 2003). A 
leucine zipper motif has been recognised in VP4, which is 
known to regulate the DNA binding activity (Johne and 
Muller, 2003). In addition, the expression of V4 has been 
linked to the induction of apoptosis of the host cells 
(Johne et al., 2000; Johne and Muller; 2003). An 
additional protein consisting of the 125 C-terminal amino 
acid residues of VP3 has been recognised in simian virus 
40 (SV40) of mammalian polyomavirus and named VP4. 
However, the VP4 in SV40 has no similarities in terms of 
sequence, structure and biological properties compared to 
the VP4 of avian polyomaviruses (Daniels et al., 2007).  
 
Phylogenetic Relationships of Polyomavirus  
 
The family Polyomaviridae are categorised as group 
1 virus in the Baltimore classification system as they 
comprise double stranded DNA genomes (Neu et al., 
2008). In 2015, taxonomy released by International 
Committee on Taxonomy of Virus documented 73 species 
within this family under four genera (Alphapolyomavirus, 
Betapolyomavirus, Deltapolyomavirus and 
Gammapolyomavirus). APV is assigned under the genus 
Gammapolyomavirusor Avipolyomavirus (Johne et al., 
2011). Polyomaviridae shares the similar virion structure 
as Papillomaviridae, comparable genome organization, 
mechanisms of replication, cell cycle regulation as well as 
tumour induction (Parrish, 2011). Members of both 
families undergo replication in nucleus, where 
Polyomaviridae DNA is transcribed from both strands, 
while Papillomaviridae DNA is transcribed from only one 
stand (Johne et al., 2000; Parrish, 2011). Several distinct 
features have been observed between mammalian 
polyomaviruses and APV as such in region encoding for 
large tumour (T) antigen, non-coding regulatory region as 
well as agnoproteins (Johne et al., 2000).   
The family Polyomaviridae consists of different 
polyomaviruses that infect many species such as humans, 
monkeys, rats, hamsters, and many species of birds 
majorly in a host-specific interaction (Halami et al., 2010; 
Johne et al., 2006). The first member of Polyomaviridae 
described is the mouse polyomavirus (mPyV) in 1953 on 
the transmission of mouse leukaemia (Neu et al., 2008).  
Polyomaviruses are very host specific despite the flexible 
and wide range detection methods. There was no report of 
polyomavirus first discovered in an organism and later 
detected in another, except for APV and SV40.  Human 
polyomaviruses are among the species that have been 
discovered in depth throughout these recent decades, 
which include human BK polyomavirus, JC 
polyomavirus, KI polyomavirus and WU polyomavirus 
(Johne et al., 2011). Several types of polyomaviruses have 
been identified to represent polyomaviruses of birds, 
which are APV, finch polyomavirus (FPyV), crow 
polyomavirus (CPyV), goose haemorrhagic polyomavirus 
(GHPyV) and canary polyomavirus (CaPyV) (Guerin et 
al., 2000; Halami et al., 2010; Johneet al., 2006; Stoll et 
al., 1993). Based on nucleotide sequence identity of 
greater than 50%, it has been found out that CaPyV is 
most closely related to APV and FPyV (Halami et al., 
2010).  
The phylogenetic, biological and structural data 
support the groupings of bird polyomaviruses in a 
separate group under the family Polyomaviridae (Halami 
et al., 2010; John and Muller, 2003). Based on the 
sequence analysis of genome, it has been found out that 
avian polyomaviruses segregate independently from the 
mammalian ones (Parrish, 2011). This indicates a long-
standing evolutionary divergence, where the viruses group 
might end up in different genera in the future.  
 
Symptoms of Avian Polyomavirus Disease 
 
APV is an etiologic agent of a lethal multisystemic 
disease in different bird species scrutinised around the 
world (Johne and Muller, 2003). Presumptive diagnosis of 
APV infection can be deduced according to the history, 
clinical findings, and histopathologic lesions and 
characteristic gross (Mamom et al., 2009). Records of 
natural and experimental infections of APV in budgerigars 
have shown major pathological symptoms such as 
hydropericardium, ascites and hepatitis (Halami et al., 
2010; Johne and Muller, 2007).APV also induces 
histologic lesions focal necrosis with enlarged clear 
basophilic intracellular inclusions in the spleen, liver and 
many other tissues (Bert et al., 2005; Parrish, 2011). 
Disease symptoms are associated with increased mortality 
of the young captive psittacines. APV infections may 
cause acute lethal death without premonitory signs, unlike 
mammalian polyomaviruses infections which are usually 
harmless yet persistent towards the non-
immunocompromised hosts (Johne et al., 2000). In most 
cases, the birds affected with APV were showing 
temporary clinical warnings such as paleness, lack of 
appetite, anorexia, subcutaneous haemorrhages and crop 
stasis before dying suddenly (Parrish, 2011). In critical 
form, APV disease results in full crops, reddened skin, 
feather dystrophy, scattered cutaneous haemorrhages, 
enlarged heart and liver, and eventually acute death 
Parrish, 2011). 
The incidences of diseases associated with APV 
have been reported frequently from captive population. 
Statistical analysis showed that the APV infection in birds 
from shelters and rescue centres is much higher than in 
veterinary clinics or in their natural habitats (Dolz et al., 
2013). The birds living in captivity have closer proximity 
to each other, hence the virus could spread much easier 
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among the population. The fact that the virus could 
remain in the faecal for months increase the chance of 
infection to the new-born hatchlings or recently arrived 
captives. The number of affected nests raised during the 
breeding season, and the figures went higher as the 
nestling cycles continued (Tomasek et al., 2007). 
Nestlings in captivity between as early as 1 week to 5 
months of age are most vulnerable to this virus, having a 
mortality rate up to 100% (Hsu et al., 2006; Tomasek et 
al., 2007). APV induced disease is usually characterised 
by deaths in hand-raised nestlings of non-budgerigar 
psittacine species (Tomasek et al., 2007). The infected 
birds can shed the virus in the faeces for up to 6 months 
(Parrish, 2011). A high prevalence of APV infection and 
virus shedding were recognised in asymptomatic 
cockatiels, which lasted for more than 18 months due to 
possible tolerance of the host to the APV (Tomasek et al., 
2007). The avian species that survived from the APV 
infection during young stage would develop feather 
ailment as a significant symptom (Johne and Muller, 
2007). 
The AVP disease may be linked with a milder 
disease of budgerigars called French moult, which results 
in chronic disorders of feather formation (Parrish, 2011). 
Subclinical infection of polyomavirus has been identified 
in zebra finches (Poephila guttata), kookaburra (Dacelo 
novaeguineae) and Ross’s turaco (Musophaga rossae) 
(Parrish, 2011). While most of the birds found to be 
infected with APV were in grown in captivity, the only 
species shown to have APV infection in its own natural 
habitat is the sulphur-crested cockatoo (Cacatua gallerita) 
in Australia (Parrish, 2011).  
 
Status of Avian Polyomavirus Worldwide  
 
The current status of epidemiology of APV all over 
the world has not been fully recorded. Only the studies of 
the virus and disease caused within several countries are 
used as references, and few were done together with 
detection of beak and feather disease virus (BFDV) (Bert 
et al., 2004; Dolz et al., 2013; Hsu et al., 2006,). Clinical 
diagnosis and molecular analysis such as polymerase 
chain reaction (PCR) and rolling circle amplification 
(RPA) are among the methods used to verify and 
characterised the presence of this virus. The samples taken 
were from different sources, either veterinary clinics, 
captive breeders, rescue centres or shelters.  
A total of 269 samples from 19 psittacine species 
were showing APV infection at the rate of 4.8 % (13/269) 
in Costa Rica between 2005 and 2009 (Dolz et al., 2013). 
A prevalence of 19.7% of BFDV was detected in the same 
study, while 3.3% of the birds were found out to be 
infected with both APV and BFDV disease (Dolz et al., 
2013). Based on this study, birds infected with BFDV 
would have 6.24 times more chance to be infected with 
APV (Dolz et al., 2013). Within the same duration of 
years in Poland, a total number of 751 symptom–free 
birds from 31 genera and 59 species were tested for 
BFDV and APV (Piasecki and Wieliczko, 2010). Results 
show that the occurrence of BFDV was 25.3% and APV 
was 22.2%, a percentage that is enough to spark a 
concern. However, in Italy, APV was detected in only 
0.8% birds from a total of 877 samples (Bert et al., 2004). 
The samples were collected from 18 Italian psittacine 
breeding centres and four trade centres for over a 4-year 
period. High mortality of nestling cockatiels (Nymphicus 
hollandicus) was studied in a breeding flock of exotic 
birds in Central Slovakia, showing all nestlings in affected 
nests of 14 breeding adults died within 1 week of age 
(Tomasek et al., 2007). However, from a survey in 
Germany, there was no positive detection of APV 
infection in 85 symptom-free birds of 20 different 
psittaformers from 30 breeders all over the country 
(Rahaus and Wolff, 2004). This indicated that the 
occurrence of persistent APV infection among the captive 
psittacine populations in Germany is relatively low.  
In South-East Asia region, several surveys have 
been conducted to screen the epidemiology of APV 
disease infection. In Taiwan, from a total of 165 psittacine 
birds belonging to 22 genera, 15.2% were found out to be 
positive of APV (Hsu et al., 2006). A study done in 
Thailand showed that 8.1% or 10 over 124 samples were 
positive to APV via multiplex polymerase chain reaction 
on captive psittacine samples of 10 genera and 20 species 
(Fungwitaya et al., 2009). A recent local study in Klang 
Valley, Malaysia, has shown the presence of APV in six 
out of 30 pooled samples (20.0%) of psittacine birds from 
four different breeders (Zanon, 2016).  
 
Vaccine against Avian Polyomavirus 
 
After the discovery of APV, efforts on inventing an 
effective vaccine against the virus did not end up in 
success due to the presence of subclinical infections and 
acutely diseased carrier birds (Ritchie et al., 1998). The 
lack of knowledge in characterising the epidemiology and 
pathophysiology of the infection has affected the vaccine 
discovery too. Consequently, positive incidences APV in 
many studies have signified the spread of this virus 
worldwide. This resulted in substantial economic deficits 
and psychological distress for aviculturists and pet store 
owners every year. Hence the demand of preventing the 
virus infection and minimising its impact are increasing 
rapidly.  
Virus neutralisation techniques as well as 
immunodiffusion have been utilised to establish anti-
polyomavirus antibodies in psittacine birds since the 
1980s. Several types of conventional adjuvants were 
evaluated to identify their effect on the immunogenicity of 
inactivated APV, which includes Equimune, E-3, 
Acemannan and mineral oil (Ritchie et al., 1994). The 
adjuvants were however found to cause muscular 
necrosis, and the oil-adjuvanted vaccines were correlated 
to death of the treated samples (Ritchie et al., 1998).  
The introduction of inactivated APV vaccine by 
Biomune Company (USA) was proposed to be 
instrumental to cease the outbreaks of APV disease in 9 
parrot nurseries (Phalen, 1998; Ritchie et al., 1998). The 
utilisation of the virus vaccine approved by USDA was 
reported to halt the mortality in each aviary within 4 
weeks twice vaccinations. The inactivated avian 
polyomavirus vaccine safety was evaluated in 1823 
psittacine birds from more than 80 species (Ritchie et al., 
1998). The study has also shown that the APV vaccine is 
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immunogenic and efficacious in mature and immature 
psittacines. The example of current vaccine available is 
Psittimune® APV by Creative Science (USA), which 
contains antigenic isolate of APV and adjuvant for 
enhanced response to vaccination. Primary immunization 
is given to young birds at 5 weeks of age, and the second 
dose is given after 2-3 weeks after the initial one.  
In term of prevention, management practice itself is 
adequate to avert the introduction of APV into a nursery 
(Phalen et al., 2000). Up to now, there is no known 
treatment for APV disease. While vaccination is available, 
this option may cost as much as USD40-60 per bird and 
booster shots are essential each year. Certain psittacine 
species are still susceptible to the virus infection. Most of 
the adult psittacines are rarely to develop the disease, as 
the exposure towards the virus at heightened natural body 
immunity in correlation with age. Besides, the 
effectiveness of the vaccine in younger birds is in 
question, as the nestlings would still be having a risk of 
being exposed to the APV infection before they complete 
the full vaccination. 
 
CONCLUSION 
 
While typical infection of APV occurs in a well-
fleshed juvenile and just before fledgling age, most of 
adult birds can act as a carrier of APV without showing 
any clinical warnings to other susceptible birds around 
them.  Therefore, containment of the virus is relatively 
difficult. An advisable method of prevention would be to 
isolate the young birds until they complete their full 
vaccination. Clinical diagnosis and molecular analysis 
from swabs and faecal samples can also be done routinely 
to verify the circulation of this virus. 
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